Foodborne Pathog Dis 2009,6(5):569–575 PubMedCrossRef 6 Olsen SJ

Foodborne Pathog Dis 2009,6(5):569–575.PubMedCrossRef 6. Olsen SJ, Patrick M, Hunter SB, Reddy V, Kornstein L, MacKenzie WR, Lane K, Bidol S, Stoltman GA, Frye DM, et al.: Multistate outbreak of Listeria Tideglusib nmr monocytogenes infection linked to delicatessen turkey

meat. Clin Infect Dis 2005,40(7):962–967.PubMedCrossRef 7. Miya S, Takahashi H, Ishikawa T, Fujii T, Kimura B: Risk of Listeria monocytogenes Temsirolimus molecular weight contamination of raw ready-to-eat seafood products available at retail outlets in Japan. Appl Environ Microbiol 2010,76(10):3383–3386.PubMedCrossRef 8. CDC: Multistate outbreak of Listeriosis associated with Jensen Farms cantaloupe – United States, August-September 2011. MMWR Morb Mortal Wkly Rep 2011,60(39):1357–1358. 9. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM: Foodborne illness acquired in the United States–major pathogens. Emerg Infect Dis 2011,17(1):7–15.PubMed 10. FAO/WHO: Food and Agriculture Organization World Health Organization. Risk assessment of Listeria monocytogenesin ready to eat foods-Technical report. 2004, 1–267. 11. Graves LM, Helsel LO, Steigerwalt AG, Morey RE, Daneshvar MI, Roof SE, Orsi RH, Fortes ED, Milillo SR, den

Bakker HC, et al.: Listeria marthii sp. nov., isolated from the natural environment, Finger Lakes National Forest. Int J Syst Evol Microbiol 2010,60(Pt 6):1280–1288.PubMedCrossRef 12. Leclercq A, Clermont D, Bizet C, Grimont PA, Le Fleche-Mateos A, Roche SM, Buchrieser Etomidate C, Cadet-Daniel V, Le MA, Lecuit P505-15 M, et al.: Listeria rocourtiae sp. nov. Int J Syst Evol Microbiol 2010,60(Pt 9):2210–2214.PubMedCrossRef 13. Guillet C, Join-Lambert O, Le MA, Leclercq A, Mechai F, Mamzer-Bruneel MF, Bielecka MK, Scortti M, Disson O, Berche P, et al.: Human listeriosis caused by Listeria ivanovii. Emerg Infect Dis 2010,16(1):136–138.PubMedCrossRef 14. Banada PP, Bhunia AK: Antibodies and immunoassays for detection of bacterial pathogens. In Principles

of Bacterial Detection: Biosensors, Recognition Receptors and Microsystems. Edited by: Zourob M, Elwary S, Turner A. Manchester: Cambridge University; 2008:567–602.CrossRef 15. Bierne H, Cossart P: Listeria monocytogenes surface proteins: from genome predictions to function. Microbiol Mol Biol Rev 2007,71(2):377–397.PubMedCrossRef 16. O’Connor L, O’Leary M, Leonard N, Godinho M, O’Reilly C, Coffey L, Egan J, O’Mahony R: The characterization of Listeria spp. isolated from food products and the food-processing environment. Lett Appl Microbiol 2010,51(5):490–498.PubMedCrossRef 17. Oravcova K, Trncikova T, Kuchta T, Kaclikova E: Limitation in the detection of Listeria monocytogenes in food in the presence of competing Listeria innocua. J Appl Microbiol 2008,104(2):429–437.PubMed 18. Besse NG, Barre L, Buhariwalla C, Vignaud ML, Khamissi E, Decourseulles E, Nirsimloo M, Chelly M, Kalmokoff M: The overgrowth of Listeria monocytogenes by other Listeria spp.

Emerg Infect Dis 2005,11(12):1835–1841 PubMed 23 Svensson K, Lar

Emerg Infect Dis 2005,11(12):1835–1841.PubMed 23. Svensson K, Larsson P, Johansson D, Bystrom M, Forsman M, Johansson A: Evolution of subspecies of Wortmannin clinical trial Francisella tularensis. J Bacteriol 2005,187(11):3903–3908.CrossRefPubMed 24. Oyston PC: Francisella tularensis: unravelling the secrets of an intracellular pathogen. J Med Microbiol 2008,57(Pt 8):921–930.CrossRefPubMed 25. Thomas R, Johansson A, Neeson B, Isherwood K, Sjostedt A, Ellis J, Titball RW: Discrimination of human pathogenic subspecies of Francisella tularensis by using restriction fragment length polymorphism. J Clin Microbiol 2003,41(1):50–57.CrossRefPubMed 26. Johansson A, Ibrahim A, Goransson I, Eriksson U, Gurycova D, Clarridge JE 3rd,

Sjostedt A: Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes Selleckchem MS-275 the two

major subspecies of Francisella tularensis. J Clin Microbiol 2000,38(11):4180–4185.PubMed 27. de la Puente-Redondo VA, del Blanco NG, Gutierrez-Martin see more CB, Garcia-Pena FJ, Rodriguez Ferri EF: Comparison of different PCR approaches for typing of Francisella tularensis strains. J Clin Microbiol 2000,38(3):1016–1022.PubMed 28. Vogler AJ, Birdsell D, Wagner DM, Keim P: An optimized, multiplexed multi-locus variable-number tandem repeat analysis system for genotyping Francisella tularensis. Lett Appl Microbiol 2009,48(1):140–144.CrossRefPubMed Authors’ contributions GAP- planned, developed and co-coordinated the GNAT2 project, analyzed the data, wrote the manuscript; MHH – bioinformatic tool development and data analysis, contributed to the progress of the project and manuscript writing; JMP – contributed to the data analysis and manuscript preparation; SP- wet lab analysis, performed resequencing assays of the samples; SAK- bioinformatic data analysis, preparation of tables and figures; MJW- contributed to the data analysis and manuscript preparation; CM- data collection for the SNP typing assay of samples; MJ- contribution towards development and optimization of the SNP typing assay; MES-participated

in data analysis and manuscript preparation; RDF-project oversight; SNP-project design, manuscript contribution and project oversight. All authors read and approved the final manuscript.”
“Background Mycobacterium avium subspecies paratuberculosis (Map) causes paratuberculosis or Johne’s disease, a fatal chronic granulomatous enteritis. The disease occurs worldwide and is responsible for significant economic losses to livestock and associated industries [1, 2]. It is endemic in Europe with only Sweden maintaining paratuberculosis-free status. The epidemiology is poorly understood and there are important questions still to resolve, particularly with respect to interspecies transmission. Map infects principally ruminants but over the past decade it has become apparent that the organism has a much broader host range including monogastric species [3–5].

Sci Fund (201003387), GDNSF (S2011040004850), and partially by S

Sci. Fund (201003387), GDNSF (S2011040004850), and partially by Shanghai Supercomputer Center. References 1. Evans MH, Joannopoulos JD, Pantelides ST: Electronic and mechanical properties of planar and tubular boron structures. Phys Rev B 2005, 72:045434–045439.CrossRef 2. Kunstmann J, Quandt A: Broad boron sheets and boron nanotubes: an ab initio study of structural, electronic, and mechanical properties. Phys Rev B 2006, 74:035413–035426.CrossRef 3. Lau KC, Pati R, Pandey R, Pineda AC: First-principles study of the stability and electronic properties of sheets and nanotubes of elemental boron. Chem Phys Lett 2006, 418:549–554.CrossRef 4. Cabria I, López MJ, Alonso JA: Density functional calculations

of hydrogen adsorption on boron nanotubes and boron sheets. Nanotechnology this website 2006, 17:778–786.CrossRef 5. Szwacki NG, Sadrzadeh A, Yakobson BI: B80

fullerene: an ab initio prediction of geometry, stability, and electronic structure. Phys Rev Lett 2007, 98:166804–166807.CrossRef 6. Tang H, Ismail-Beigi S: Novel precursors for boron nanotubes: the competition of two-center and three-center bonding in boron sheets. Phys Rev Lett 2007, 99:115501–115504.CrossRef 7. Yang X, Ding Y, Ni J: Ab initio prediction of stable boron sheets and boron nanotubes: structure, stability, and electronic properties. Phys Rev B 2008, 77:041402–041405. R. 8. Singh AK, Sadrzadeh A, Yakobson BI: Probing properties of boron α-tubes by ab initio calculations. Nano Lett 2008, 8:1314–1317.CrossRef 9. Prasad DLVK, Jemmis ED: Stuffing improves the stability of fullerenelike boron clusters. Phys Rev Lett 2008, 100:165504–165507.CrossRef 10. Szwacki NG: Boron fullerenes: a first-principles study. Nanoscale eFT-508 Res Lett 2008, 3:49–54.CrossRef 11. Lau KC, Orlando R, Pandey R: First-principles study of crystalline bundles of single-walled boron nanotubes with small diameter. J Phys Condens Matter 2008, 20:1–10. 125202CrossRef 12. Yan QB, Zheng QR, Su G: Face-centered-cubic B80 metal: density functional theory calculations. Phys Rev B 2008, 77:224106–224110.CrossRef 13. Zope RR, Baruah T, Lau KC, Liu AY, Pederdon MR, Dunlap BI: Boron fullerenes: from B80 to hole doped boron sheets. Phys Rev B 2009,

79:161403R.CrossRef 14. Otten BCKDHB CJ, Lourie OR, Yu MF, Cowley JM, Dyer MJ, Ruoff RS, Buhro WE: Crystalline boron nanowires. J Am Chem Soc 2002, 124:4564–4565.CrossRef 15. Wang YQ, Duan XF, Cao LM, Wang WK: One-dimensional growth mechanism of amorphous boron nanowires. Chem Phys Lett 2002, 359:273–277.CrossRef 16. Wang DW, Lu JG, Otten CJ, Buhro WE: Electrical transport in boron nanowires. Appl Phys Lett 2003, 83:5280–5282.CrossRef 17. Yun SH, Dibos A, Wu JZ, Kim DK: Effect of quench on crystallinity and GSK2245840 ic50 alignment of boron nanowires. Appl Phys Lett 2004, 84:2892–2894.CrossRef 18. Gindulyte A, Lipscomb WN, Massa L: Proposed boron nanotubes. Inorg Chem 1998, 37:6544–6545.CrossRef 19. Boustani I, Quandt A, Hernandez E, Rubio A: New boron based nanostructured materials.

Previous investigations show that the phase transformation from d

Previous investigations show that the phase transformation from diamond cubic phase to the β-Sn phase of silicon selleck screening library occurs MAPK inhibitor during nanometric cutting, and the amorphous silicon is observed after machining. Figure

10 displays the snapshots of nanometric cutting on cooper, silicon, and germanium, respectively. The atoms in Figure 10a are colored according to the value of the centro-symmetric parameter, and the atoms with centro-symmetric parameter less than 3 are hidden, representing the perfect FCC structure including elastic deformation [22, 23]. It can be seen that the dislocations extending into the material are the dominant deformations for copper during nanometric cutting. Most of the dislocations are initially parallel to 111 planes [17]. The atoms in Figure 10b,c are colored according to their coordination number, and the fourfold coordinated atoms far away from the machined region are hidden, which indicate

the diamond cubic phase and its distorted structure. Ro 61-8048 solubility dmso The coordination number and atomic bond length are usually used to identify the structural phase formation during nanoindentation and nanometric cutting of silicon [24–26]. Generally, in the case of silicon and germanium, the atoms with coordination number of 4 indicate a covalent bonded system with a diamond cubic structure. The sixfold coordinated atoms are thought as the β-Sn phase, and the fivefold coordinated atoms indicate the bct5 structure, which is considered as an intermediate in the formation of sixfold-coordinated β-Sn phase [16, 27]. The atoms with coordination number of 7 or more may indicate the complete Exoribonuclease amorphous structure under pressure, and the threefold or twofold coordinated atoms are indicative of the dangling bonds on the surface and sides of the work material [7, 16].

It can be seen from Figure 10b that the phase transformation and amorphization instead of dislocation formation are the dominant deformations on machined surface and subsurface. The mechanism of nanometric cutting of germanium is similar with that of silicon from the snapshot shown in the Figure 10c. Figure 10 Cross-sectional view of subsurface deformation of copper, silicon, and germanium during nanometric cutting. The perfect FCC structure and diamond cubic structure are hidden. The change of coordination number for germanium atoms during nanocutting is recorded, as displayed in Figure 11. During the nanometric cutting, the numbers of fivefold and sixfold coordinated atoms increase while the number of fourfold coordinated atoms decreases, which means that the phase transformation from diamond cubic structure to β-Sn phase occurs.

Five pieces (3 cm × 3 cm per piece) of rumen wall were cut from t

Five pieces (3 cm × 3 cm per piece) of rumen wall were cut from the rumen of each goat. At the same time, microorganisms on the rumen epithelium were collected by scraping with glass slides. The rumen ISRIB in vitro contents were divided

TPX-0005 into rumen fluid and solid fractions by squeezing through two layers of cheesecloth and centrifugation at 800 × g for 15 min at 4°C. All samples were stored at −70°C. Establishment and maintenance of the mixed-cultures of anaerobic fungi and methanogens The mixed cultures of anaerobic fungi and methanogens were enriched from rumen content according to our previous study [29]. Rumen content was collected into pre-warmed thermos flasks from three rumen fistulated goats (Haimen goat) fed with Leymus Chinensis and immediately transported to the laboratory. The rumen content was homogenized prior to being squeezed through two layers of cheesecloth under anaerobic conditions. The resultant rumen liquid (5 ml) was placed into a CO2 gassed serum bottle with 45 ml of anaerobic diluting solution [30]. Three 10 ml aliquots were removed from the bottle and inoculated into three pre-warmed bottles (39°C) containing

90 ml of growth medium (Mixed-cultures). The mixed-cultures were incubated at 39°C in the incubator (PYX-DHS-50 × 65, Shanghai, China) without shaking and transferred every 3–4 days. OSI-744 In this study, the mixed cultures were transferred more than 62 times. A 7 ml portion of the culture supernatant from the 5th, 15th, 25th, 35th, 45th, 55th, and 62nd subcultures and 1.5 ml of the goat rumen content were collected for DNA extraction. Orpin’s medium [31] was prepared by boiling the mixture for 5 min prior to pumping with CO2 to remove O2. After 2–3 h gassing with CO2, the medium was then dispensed into 160 ml

serum bottles sealed with butyl rubber septa and aluminium crimp-seals (Bellco Glass Inc., Vineland, New Jersey, USA) in anaerobic condition. The growth medium composed of Orpin’s medium containing penicillin RANTES (1600 IU/ml) and streptomycin (2000 IU/ml) and 1% ground rice straw (1 mm) as the substrate. Throughout this study, the growth of methanogens relied on the anaerobic fungi in the co-cultures and no additional hydrogen was added. Methane produced by the mixed cultures was detected by GC during transfer, and the presence of methanogens in the mixed cultures was also monitored by PCR-DGGE. In our previous study, transfer frequency was conducted to investigate its effect on the diversity and activity of enriched ruminal cultures of anaerobic fungi and methanogens in the mixed cultures [18]. DNA samples extracted from our previous study [16] were further analyzed for the novel RCC survival in the present study. Briefly, the mixed cultures of anaerobic fungi and methanogens were subcultured with three transfer frequencies (three-day, five-day, seven-day), respectively, each with triplicates. A portion of 5 ml culture supernatants from each of the 2nd, 4th, and 9th subcultures was collected for DNA extraction.

One derivative

containing an RDD triplet in the receptor-

One derivative

containing an RDD triplet in the receptor-binding site was obtained from the serotype Asia 1 field isolate after a single cattle-to-pig transmission and subsequent BHK-21 in vitro passage. Sequence analysis of 10 biological clones of the VP1 encoding region of this population demonstrated that RDD viruses instead of the original RGD virus became predominant at an early phase of Asia1/JS/CHA/05 quasispecies evolution. Unexpectedly, however, both RGD and RSD viruses were obtained from the Asia1/JSM4 population that were generated after four serial passages of the Asia1/JS/CHA/05 field isolate in suckling mice, via intraperitoneal inoculation. The population equilibrium of RSD mutant and ancestor viruses was maintained after 20 passages of the Asia1/JSM6 population in BHK-21 cells. Although RDD- or RSD-containing FMDV are unusual, they were genetically stable upon extended replication in cell culture. Our results suggest that, in the context of the capsid proteins of Asia1/JS/CHA/05, a highly conserved RGD motif is not essential for replication in vitro and in vivo, suggesting functional flexibility of FMDV to enter cells

in response to environmental modifications. Like other RNA viruses, FMDV exists as closely related but non-identical genomes, termed viral quasispecies [30, 31]. Genetic diversity is an intrinsic property of the quasispecies, which arise due to the lack of proofreading selleck compound activity during viral genome replication, a short replication cycle, and other environmental selective pressures [32, 33]. Our observations showed that evolution of FMDV population exhibited receptor binding motif diversity (genetic diversity) subjected to short-term passage of field isolate in different environments. From the standpoint of RNA virus population evolution, one possible scenario could explain this observation. The early interactions between viruses and host cells exert major selective force on virus Selleck AZD1152-HQPA populations, thus, the Urocanase variants (RSD- and RDD-containing viruses) may already be

present at low frequency in the natural population that are possibly more fit in new environments and become dominant strains. While this presumption is contrary to the view that the RGD triplet is highly conserved among natural isolates of FMDV, there is direct evidence that an RDD containing field virus was isolated from pigs during a type Asia 1 FMD outbreak in China. RDD-containing FMDV VP1 genes were amplified from sheep oesophageal-pharyngeal fluids (OP-fluids) collected during 2006 from a sheep herd in the region of China that had endemic Asia 1 serotype FMDV [34, 35]. The emergence of these non-RGD mutants in nature is likely to be influenced by specific epidemiological and immunological aspects of host-virus interaction as well as the quasispecies composition of the viral population [36–39].

aeruginosa PAO1 Scale bar 100 μm Discussion P mosselii was for

aeruginosa PAO1. Scale bar 100 μm. Discussion P. check details mosselii was formally described as a novel species in 2002 through a polyphasic taxonomic approach including 16SrDNA phylogeny, numerical analysis, DNA–DNA hybridization, thermal stability of DNA–DNA hybrids and siderophore-typing methodology [19]. The several strains of P. mosselii described to date were isolated in hospital and some have been suggested

as emerging human pathogens [19–21]. Our study aimed Evofosfamide in vitro at investigating the virulence potential of two of these strains, namely ATCC BAA-99 and MFY161, belonging to the same cluster strongly related to the hospital-isolated P. putida on the basis of both oprD or oprF-linked phylogenies [22]. Although P. putida species is mostly known for its huge capacity in degradation of numerous carbon sources [23], some clinical strains have emerged, causing infections in immunosuppressed hosts and patients with invasive medical devices. More recently, P. putida has been involved in war wound infection, and should be considered as a potential human pathogen, for a review see Carpenter et al. [24]. In the present study, we further investigated the cytotoxicity of OSI-906 chemical structure P. mosselii ATCC BAA-99 and MFY161 strains, and show that they provoked the lysis of the intestinal epithelial cells Caco-2/TC7, with a major damage obtained after infection with P. mosselii MFY161.

The cytotoxic levels were lower compared to the well-known opportunistic pathogen P. aeruginosa PAO1 but almost similar to those observed for P. mosselii strains on rat glial cells [21], and for the clinical strain P. fluorescens MFN1032 on Caco-2/TC7 cells [17]. The gentamicin exclusion test showed that P. mosselii ATCC BAA-99 and MFY161 can enter Caco-2/TC7 cells. The invasion capacity of the two P. mosselii strains studied was similar and lower than that of the pathogen P. aeruginosa PAO1. The bacterial proinflammatory effect of P. mosselii ATCC BAA-99 and MFY161 was then assessed by measuring the secretion of IL-6 and IL-8 cytokines in Caco-2/TC7 after 24 h of infection. The results showed that the two strains did not induce the production of these proinflammatory cytokines. We hypothesize

that this may serve as a strategy for P. mosselii to escape the immune system. However, P. mosselii ATCC BAA-99 and MFY161were found to strongly increase the secretion Ibrutinib of HBD-2. Human beta-defensins are known to play a key role in host defense. In fact, in addition to their potent antimicrobial properties against commensal and pathogenic bacteria [25], beta-defensins were demonstrated to function as multieffector molecules capable of enhancing host defense by recruiting various innate as well as adaptive immune cells to the site of infection. Nevertheless, some pathogens can be resistant to HBD-2 [26] and surprisingly can induce and divert HBD-2 secretion in intestinal epithelial cells to enhance its capacity of virulence [27]. The effect of P.

“Background Creatine is a glycine-arginine metabolite synt

“Background Creatine is a glycine-arginine metabolite synthesized in the liver, pancreas, and kidneys and is naturally stored by skeletal and cardiac muscles as an

energy supplier in the phosphocreatine form [1]. Muscle phosphocreatine plays a key role in anaerobic ATP production in muscles via the highly exergonic reaction catalyzed by creatine kinase. Thus, creatine monohydrate has become an increasingly popular dietary supplement, particularly for improvement of explosive strength performances [2, 3]. Recent findings have also proposed that creatine supplementation could efficiently restrain oxidative processes in vitro[4, 5]. At least two antioxidant mechanisms are currently Tanespimycin supplier Birinapant suggested for creatine: (i) direct scavenging of hydroxyl (HO·) and nitrogen dioxide (NO2 ·) radicals [6–8] by the creatine N-methylguanidino moiety; and (ii) lasting use of anaerobic selleck chemical energy-supplying pathways

because of accumulated creatine and preserved glycogen in skeletal muscles [9–11]. A plethora of data has revealed that reactive oxygen species (ROS) are overproduced during and after anaerobic/resistance exercise, but from cellular sources other than mitochondria [12, 13]. Induced by an apparent ischemia-reperfusion process during intense contractile activity of the resistance exercise, accumulating concentrations of AMP in exhausting muscle fibers activate the capillary enzyme xanthine oxidase – belonging to the purine catabolic pathway – which catalyzes the conversion of hypoxanthine into uric acid with concomitant

overproduction of superoxide radicals (O2 ·-) and hydrogen peroxide (H2O2) [14]. In turn, O2 ·- and H2O2 are closely related to the production of the highly reactive hydroxyl radical (HO·) by iron-catalyzed reactions (Eqs. 1 and 2) that harmfully initiate 2-hydroxyphytanoyl-CoA lyase oxidizing processes in cells, such as lipoperoxidation [15]. (1) (2) Although some information linking iron metabolism and oxidative stress in exercise/sports is currently available, data reporting changes in iron homeostasis of plasma during/after one single bout of exercise compared to antioxidant responses are still scarce. Sources of iron overload in plasma during/after exercise are also unclear. Noteworthy, many authors have reported evidence of a “sport anemia” syndrome in athletes and experimental animals – especially in females – as a result of chronic iron deficiency imposed by prolonged training periods [16, 17]. Thus, based on iron-redox chemistry, progressive ROS overproduction could be triggered by iron overload in plasma and extracellular fluids during/after anaerobic exercise [18, 19]. Together, these redox changes have been increasingly associated to lower athletic performance, early fatigue, inflammatory processes, and higher risks of post-exercise injuries [20–22].

Semin Oncol 1998,25(1 Suppl 2):42–48

Semin Oncol 1998,25(1 Suppl 2):42–48.PubMed 251. Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR, van Dongen JJ, Szczepanski T: Acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2002, 162–192. 252. Stone RM, O’Donnell MR, Sekeres MA: Acute myeloid leukemia. Hematology Am Soc AZD6244 mw Hematol Educ Program 2004, 98–117. 253. Shah NP: Medical management of CML. Hematology Am Soc Hematol Educ Program 2007, 371–375. 254. Quintas-Cardama A, Cortes JE: Chronic myeloid leukemia: diagnosis and treatment. Mayo Clin Proc 2006,81(7):973–988.PubMed 255. Yee KW, O’Brien SM: Chronic lymphocytic leukemia:

diagnosis and treatment. Mayo Clin Proc 2006,81(8):1105–1129.PubMed 256. Kay NE, Hamblin TJ, Jelinek DF, Dewald GW, Byrd JC, Farag S, Lucas M, Lin T: Chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2002, 193–213. 257. Fagioli F, Zecca M, Locatelli F, Lanino E, Uderzo C, Di Bartolomeo P, Berger M, Favre C, Rondelli R, Pession A, et al.: Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission. J Pediatr Hematol Oncol 2008,30(8):575–583.PubMed 258. Frassoni F, Gualandi F, Podesta M, Raiola AM, Ibatici A, Piaggio G, Sessarego M, Sessarego N, check details Gobbi M, Sacchi N, et al.:

Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008,9(9):831–839.PubMed 259. Ruiz-Arguelles GJ, Gomez-Almaguer D, Morales-Toquero A, Gutierrez-Aguirre CH, Vela-Ojeda J, Garcia-Ruiz-Esparza MA, Manzano C, Karduss A, Stattic concentration Sumoza A, de-Souza C, et al.: The early referral for reduced-intensity Erastin nmr stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter study. Bone Marrow Transplant 2005,36(12):1043–1047.PubMed 260. Oehler VG, Radich JP, Storer B, Blume KG, Chauncey T, Clift R, Snyder DS, Forman SJ, Flowers ME, Martin P, et al.: Randomized trial of allogeneic related bone

marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia. Biol Blood Marrow Transplant 2005,11(2):85–92.PubMed 261. Ohnishi K, Ino A, Kishimoto Y, Usui N, Shimazaki C, Ohtake S, Taguchi H, Yagasaki F, Tomonaga M, Hotta T, et al.: Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemia. Int J Hematol 2004,79(4):345–353.PubMed 262. Das M, Saikia TK, Advani SH, Parikh PM, Tawde S: Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia. Bone Marrow Transplant 2003,32(2):125–129.PubMed 263. Mohty M, Labopin M, Tabrizzi R, Theorin N, Fauser AA, Rambaldi A, Maertens J, Slavin S, Majolino I, Nagler A, et al.

Nature 2007, 448:501–505 PubMedCrossRef 31 DeFilippis VR, Alvara

Nature 2007, 448:501–505.PubMedCrossRef 31. DeFilippis VR, Alvarado D, Sali T, Rothenburg S, Fruh K: Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J Virol 2010, 84:585–598.PubMedCrossRef 32. Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL: Inhibition of PKR by

RNA and DNA viruses. Virus Res 2006, 119:100–110.PubMedCrossRef 33. Chang HW, Watson JC, Jacobs BL: The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 1992, 89:4825–4829.PubMedCrossRef 34. Romano PR, Zhang F, Tan SL, Garcia-Barrio MT, Katze MG, Dever TE, Hinnebusch AG: Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol Cell Biol 1998, 18:7304–7316. 29PubMed 35. Beattie

see more E, Tartaglia J, Paoletti E: Vaccinia virus-encoded eIF-2α homolog the antiviral effect of interferon. Virology 1991, 183:419–422.PubMedCrossRef 36. Dar AC, Sicheri F: X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. Mol Cell 2002, 10:295–305.PubMedCrossRef 37. Yu YX, Bearzotti M, Vende P, Ahne W, Bremont M: Partial mapping and sequencing of a fish iridovirus genome reveals genes homologous to the frog virus 3 p31, p40 and human eIF2alpha. Virus Res 1999, 63:53–63.PubMedCrossRef 38. Essbauer S, Bremont M, Ahne W: Comparison of the eIF-2alpha homologous proteins of seven ranaviruses (Iridoviridae). Virus Genes 2001, 23:347–359.PubMedCrossRef 39. Majji S, LaPatra S, Long SM, Sample R, Bryan L, Sinning

A, Chinchar VG: Rana catesbeiana virus Z (RCV-Z): a novel pathogenic ranavirus. Dis Aquat Organ 2006, 73:1–11.PubMedCrossRef 40. Kawagishi-Kobayashi M, Silverman JB, Ung TL, Dever TE: Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2α. Mol Cell Biol 1997, 17:4146–4158.PubMed 41. Ito T, Marintchev A, Wagner G: Solution structure of human Selleck XAV 939 initiation factor eIF2alpha reveals homology to the elongation factor eEF1B. Structure 2004, 12:1693–1704.PubMedCrossRef 42. Dever TE, Sripriya R, McLachlin JR, Lu J, Fabian JR, Kimball SR, Miller LK: Disruption of cellular from translational control by a viral truncated eukaryotic translation initiation factor 2alpha kinase homolog. Proc Natl Acad Sci USA 1998, 95:4164–4169.PubMedCrossRef 43. Kawagishi-Kobayashi M, Cao C, Lu J, Ozato K, Dever TE: Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product. Virology 2000, 276:424–434.PubMedCrossRef 44. Cigan AM, Pabich EK, Feng L, Donahue TF: Yeast translation initiation suppressor sui2 encodes the alpha subunit of eukaryotic initiation factor 2 and shares sequence identity with the human alpha subunit.